ARCHIVES

NCI Director’s Office Gets Makeover In Reorganization Plan.

This article is from The Cancer Letter archive.

Vol. 32 No. 44 | December 8, 2006

Download PDF Visit The Full Archive

Related Articles

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

NCI To Lose 382 Cancer FTEs; DCE Board Gets Response From Sullivan, But No Promises

July 21, 1989

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

Bioassay Backlog Reports show Increasing Number Of Equivocal Results; Is The Program A Failure?

September 2, 1977

House approves $210 million for Dept. of Defense cancer research programs.

June 24, 2005

Recommendations For Adjuvant Therapy In Breast Cancer

September 20, 1985